Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma 1

Interventions

Carboplatin 78Cisplatin 74Bevacizumab 61Radiotherapy 59Capecitabine 58Drug Therapy 57Oxaliplatin 56tislelizumab 54toripalimab 45Paclitaxel 45anlotinib 42Gemcitabine 42Specimen Handling 41pembrolizumab 40sintilimab 37Cyclophosphamide 35130-nm albumin-bound paclitaxel 34Injections 31Pemetrexed 28Magnetic Resonance Spectroscopy 28camrelizumab 26Surgical Procedures, Operative 26lenvatinib 24apatinib 23Docetaxel 23S 1 (combination) 22Biopsy 22Fluorouracil 21Etoposide 21Immune Checkpoint Inhibitors 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Not yet recruiting × Thymopentin × Clear all
NCT06112041 2023-11-01

The Prospective Clinical Study of Precision PRaG Therapy in Elderly Patients With Advanced Solid Malignant Tumors (PRaG9.0)

Second Affiliated Hospital of Soochow University

Phase 2 Not yet recruiting
29 enrolled
Tumor-Agnostic

Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡